KR20200016960A - 흡인성 폐렴, 폐화농증 또는 폐농양의 치료제 - Google Patents

흡인성 폐렴, 폐화농증 또는 폐농양의 치료제 Download PDF

Info

Publication number
KR20200016960A
KR20200016960A KR1020207000644A KR20207000644A KR20200016960A KR 20200016960 A KR20200016960 A KR 20200016960A KR 1020207000644 A KR1020207000644 A KR 1020207000644A KR 20207000644 A KR20207000644 A KR 20207000644A KR 20200016960 A KR20200016960 A KR 20200016960A
Authority
KR
South Korea
Prior art keywords
genus
belonging
fluoro
pneumonia
bacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020207000644A
Other languages
English (en)
Korean (ko)
Inventor
마사아키 오다지마
사요코 타니오카
타카아키 스노우치
아사코 타부치
Original Assignee
교린 세이야꾸 가부시키 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 교린 세이야꾸 가부시키 가이샤 filed Critical 교린 세이야꾸 가부시키 가이샤
Priority to KR1020247019005A priority Critical patent/KR20240096794A/ko
Priority claimed from PCT/JP2018/022846 external-priority patent/WO2018230686A1/ja
Publication of KR20200016960A publication Critical patent/KR20200016960A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
KR1020207000644A 2017-06-16 2018-06-15 흡인성 폐렴, 폐화농증 또는 폐농양의 치료제 Ceased KR20200016960A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020247019005A KR20240096794A (ko) 2017-06-16 2018-06-15 흡인성 폐렴, 폐화농증 또는 폐농양의 치료제

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762520961P 2017-06-16 2017-06-16
US62/520,961 2017-06-16
JP2018068159 2018-03-30
JPJP-P-2018-068159 2018-03-30
PCT/JP2018/022846 WO2018230686A1 (ja) 2017-06-16 2018-06-15 誤嚥性肺炎、肺化膿症又は肺膿瘍の治療剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020247019005A Division KR20240096794A (ko) 2017-06-16 2018-06-15 흡인성 폐렴, 폐화농증 또는 폐농양의 치료제

Publications (1)

Publication Number Publication Date
KR20200016960A true KR20200016960A (ko) 2020-02-17

Family

ID=66213244

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207000644A Ceased KR20200016960A (ko) 2017-06-16 2018-06-15 흡인성 폐렴, 폐화농증 또는 폐농양의 치료제

Country Status (14)

Country Link
US (1) US20210137913A1 (https=)
EP (1) EP3639826A4 (https=)
JP (3) JP6618660B2 (https=)
KR (1) KR20200016960A (https=)
CN (1) CN110891571A (https=)
AU (1) AU2018283234A1 (https=)
BR (1) BR112019025960A2 (https=)
CA (1) CA3067188A1 (https=)
CL (1) CL2019003630A1 (https=)
IL (1) IL270831A (https=)
MX (1) MX2019014931A (https=)
PH (1) PH12019502835A1 (https=)
SG (1) SG11201911826VA (https=)
TW (1) TWI818910B (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005026147A1 (ja) 2003-09-10 2005-03-24 Kyorin Pharmaceutical Co., Ltd. ７−（４−置換−３−シクロプロピルアミノメチル−１−ピロリジニル）キノロンカルボン酸誘導体
WO2013069297A1 (ja) 2011-11-10 2013-05-16 杏林製薬株式会社 ７－｛（３s、４s）－３－［（シクロプロピルアミノ)メチル］－４－フルオロピロリジン－1－イル｝－６－フルオロ－１－（２－フルオロエチル）－８－メトキシ－４－オキソ－１、４－ジヒドロキノリン－３－カルボン酸の結晶

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962470A1 (de) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
WO2016148066A1 (ja) * 2015-03-13 2016-09-22 杏林製薬株式会社 呼吸器感染症治療剤
EP3305294A4 (en) * 2015-06-02 2019-02-20 Kyorin Pharmaceutical Co., Ltd. AQUEOUS MEDICINE

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005026147A1 (ja) 2003-09-10 2005-03-24 Kyorin Pharmaceutical Co., Ltd. ７−（４−置換−３−シクロプロピルアミノメチル−１−ピロリジニル）キノロンカルボン酸誘導体
WO2013069297A1 (ja) 2011-11-10 2013-05-16 杏林製薬株式会社 ７－｛（３s、４s）－３－［（シクロプロピルアミノ)メチル］－４－フルオロピロリジン－1－イル｝－６－フルオロ－１－（２－フルオロエチル）－８－メトキシ－４－オキソ－１、４－ジヒドロキノリン－３－カルボン酸の結晶

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Annals of The Japanese Respiratory Society, 49(9): 623-628, 2011.
Expert Review of Respiratory Medicine (2007), 1(1), 111-119.
Infection (Munich, Germany)(2008), 36(1), 23-30.
Nippon Kagaku Ryoho Gakkai Zasshi (1999), 47(Suppl. 1), 196-203.
The Japanese Respiratory Society, Adult Pneumonia Clinical Practice Guidelines 2017, p. 24.
The Japanese Respiratory Society, Medical/Care-related Pneumonia Clinical Practice Guidelines, p. 23.
The Journal of the Japanese Society of Internal Medicine, 99:11, November 10, 2010, p. 2746-2751.

Also Published As

Publication number Publication date
TW201906607A (zh) 2019-02-16
IL270831A (en) 2020-01-30
PH12019502835A1 (en) 2020-10-05
JP6671532B2 (ja) 2020-03-25
JP2020079330A (ja) 2020-05-28
AU2018283234A1 (en) 2019-12-12
MX2019014931A (es) 2020-02-13
US20210137913A1 (en) 2021-05-13
CL2019003630A1 (es) 2020-07-10
JP2020015769A (ja) 2020-01-30
EP3639826A4 (en) 2021-03-03
CN110891571A (zh) 2020-03-17
JPWO2018230686A1 (ja) 2019-12-12
JP6618660B2 (ja) 2019-12-11
EP3639826A1 (en) 2020-04-22
TWI818910B (zh) 2023-10-21
JP7098671B2 (ja) 2022-07-11
CA3067188A1 (en) 2018-12-20
SG11201911826VA (en) 2020-01-30
BR112019025960A2 (pt) 2020-11-03

Similar Documents

Publication Publication Date Title
RU2563809C2 (ru) Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
US10028963B2 (en) Methods for treating intrapulmonary infections
Wise Maximizing efficacy and reducing the emergence of resistance
CN111939156B (zh) 一种联合抗菌药物组合物及其应用
US20210052572A1 (en) Respiratory infection treating agent
KR20080004589A (ko) 낭성 섬유증을 포함하는 중증 감염증의 치료 및 관리
KR20200016960A (ko) 흡인성 폐렴, 폐화농증 또는 폐농양의 치료제
KR20240096794A (ko) 흡인성 폐렴, 폐화농증 또는 폐농양의 치료제
HK40098387A (zh) 吸入性肺炎、肺化脓或肺脓肿的治疗剂
HK40026671A (en) Therapeutic agent for aspiration pneumonia, lung suppuration, or lung abscess
KR20120083344A (ko) 세프타롤린을 사용한 박테리아 감염 치료용 조성물 및 방법
CN1321997C (zh) 一种稳定的噻丁啶喹啉羧酸盐在制备抗感染药物中的应用
CN114732808B (zh) 牛磺酸在制备预防和治疗耐药结核病药物中的应用
Chaprazov et al. Oral abscess associated with cranial tooth loss in green iguana (Iguana iguana)
US20040023983A1 (en) Methods of use of fluoroquinolone compounds against pathogenic helicobacter bacteria
AU2015275224C1 (en) Use of aerosolized levofloxacin for treating cystic fibrosis
Varma et al. Anaesthesia for thymectomy: Use of ketamine-dexmedetomidine without muscle relaxant
KR20080037814A (ko) 이유후 전신소모성증후군(ｐｍｗｓ)의 치료용 복합제조성물
Zhu et al. Effect of Intra-Cuff Tetracaine on Preventing Postoperative Sore Throat after Gynecological Surgery
HK40023275A (en) Ceftolozane/tazobactam for treating intrapulmonary infections

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PX0601 Decision of rejection after re-examination

St.27 status event code: N-2-6-B10-B17-rex-PX0601

X601 Decision of rejection after re-examination
J201 Request for trial against refusal decision
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

PJ1301 Trial decision

St.27 status event code: A-3-3-V10-V15-crt-PJ1301

Decision date: 20250822

Appeal event data comment text: Appeal Kind Category : Appeal against decision to decline refusal, Appeal Ground Text : 2020 7000644

Appeal request date: 20240605

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2024101001327

V15 Decision substituted

Free format text: ST27 STATUS EVENT CODE: A-3-3-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2024101001327; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : APPEAL AGAINST DECISION TO DECLINE REFUSAL